GSE214931 temozolomide 3 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214931_temozolomide_3_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214931_temozolomide_3_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214931_temozolomide_3_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214931_temozolomide_3_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

vesicle associated membrane protein 7

Gene

long intergenic non-protein coding RNA 667

Gene

long intergenic non-protein coding RNA 839

Gene

lung cancer associated transcript 1

Gene

MAGI2 antisense RNA 3

Gene

uncharacterized LOC339260

Gene

small nucleolar RNA host gene 26

Gene

FEZF1 antisense RNA 1

Gene

WT1 antisense RNA

Gene

TOX divergent transcript

  • Gene

    vesicle associated membrane protein 7


  • Gene

    long intergenic non-protein coding RNA 667


  • Gene

    long intergenic non-protein coding RNA 839


  • Gene

    lung cancer associated transcript 1


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    uncharacterized LOC339260


  • Gene

    small nucleolar RNA host gene 26


  • Gene

    FEZF1 antisense RNA 1


  • Gene

    WT1 antisense RNA


  • Gene

    TOX divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.